We develop innovative technologies at the intersection of immunology, infectious disease, and engineering to address unmet challenges in biotechnology, with a focus on delivery technologies to cross biological barriers.
Biological barriers, such as skin, are challenging to overcome. Existing solutions often lead to irritation, low delivery efficiency, and severe side effects.
OTO Biotech builds platform technologies that enable more effective, safe, scalable, and unprecedentedly autonomous delivery systems to cross biological barriers. Our approach integrates advanced molecular design, immunology-informed delivery mechanism, and data-driven optimization to accelerate the path from discovery to real-world solutions.
Our work spans early-stage research through applied development, with current focus areas including novel drug delivery strategies, formulation development for improved treatment outcomes, and translational pathways toward industrial and therapeutic use.
OTO Biotech is led by scientists and engineers with training in chemical engineering, pharmacology, and data science. We collaborate closely with academic and industry partners.
We welcome inquiries from potential collaborators, partners, and investors.
📧 info@oto-biotech.com